Latest / Durham News Today | 2 Min News | The Daily News Now!
BridgeBio Soars After Wainua Trial Fails | Durham News
BridgeBio’s stock soared after a competitor’s ATTR-CM drug flopped in a major trial—sending investors scrambling to see if BridgeBio’s own drug, Attruby, can now dominate the market. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest updates:https://sources.thednn.ai/38a8128c0813201f
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.